ATS Medical, Inc., a manufacturer of cardiac surgery products and services focused, has announced completion of its acquisition of 3F Therapeutics, a privately held company that develops and commercializes fundamentally unique tissue heart valve products.
"We believe we are now well positioned to enter the tissue heart valve market with products that are differentiated from those that are currently available and that will offer outstanding benefits to surgeons and their patients," said Michael Dale, chairman, president and CEO of ATS Medical.